Youssef N, Gurev S, Ghantous F, et al. Computationally designed proteins mimic antibody immune evasion in viral evolution. Immunity. 2025. doi:10.1016/j.immuni.2025.04.015
Publications
Smelyansky SR, Ma CW, Marando VM, et al. Exploiting thioether reactivity to label mycobacterial glycans. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(19):e2422185122. doi:10.1073/pnas.2422185122
Kannan S, Altae-Tran H, Zhu S, et al. Evolution-guided protein design of IscB for persistent epigenome editing in vivo. Nature biotechnology. 2025. doi:10.1038/s41587-025-02655-3
Witte IP, Lampe GD, Eitzinger S, et al. Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase. Science (New York, N.Y.). 2025;388(6748):eadt5199. doi:10.1126/science.adt5199
Paysan D, Radhakrishnan A, Zhang X, Shivashankar G V, Uhler C. Image2Reg: Linking chromatin images to gene regulation using genetic and chemical perturbation screens. Cell systems. 2025:101293. doi:10.1016/j.cels.2025.101293
De Jonghe J, Kim HC, Adedeji A, et al. Saturation genome editing of reveals distinct dominant and recessive neurodevelopmental disorders. medRxiv : the preprint server for health sciences. 2025. doi:10.1101/2025.04.08.25325442
Westerman KE, Gervis JE, O’Connor LJ, Udler MS, Manning AK. Polygenic scores capture genetic modification of the adiposity-cardiometabolic risk factor relationship. medRxiv : the preprint server for health sciences. 2025. doi:10.1101/2025.04.09.25324066
Yamaguchi TN, Houlahan KE, Zhu H, et al. The Germline and Somatic Origins of Prostate Cancer Heterogeneity. Cancer discovery. 2025;15(5):988-1017. doi:10.1158/2159-8290.CD-23-0882
Alduhayh S, Laskar RS, Jiang X, et al. Association of Genetic Liability to Allergic Diseases with Overall and Early-Onset Colorectal Cancer Risk: A Mendelian Randomization Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2025;34(5):722-736. doi:10.1158/1055-9965.EPI-24-0970
Sorial MN, Han JX, Koh MJ, et al. Forecasting optimal treatments in relapsed/refractory mature T- and NK-cell lymphomas: A global PETAL Consortium study. British journal of haematology. 2025. doi:10.1111/bjh.20063